Workflow
海外市场拓展
icon
Search documents
美团-W:竞争加剧致亏损,新业务盈利,预测Q4一致预期营收866.14~963.14亿元
Xin Lang Cai Jing· 2025-12-19 12:48
Core Insights - Meituan-W is expected to report Q4 revenue between 866.14 billion to 963.14 billion yuan, reflecting a year-on-year change of -2.1% to 8.8% [1][6] - The anticipated net profit for Q4 is projected to be between -184.36 billion to -95.89 billion yuan, indicating a significant year-on-year decline of -396.3% to -254.1% [1][6] - Adjusted net profit for Q4 is forecasted to range from -172.43 billion to -88.83 billion yuan, with a year-on-year change of -275.1% to -190.2% [1][6] Revenue and Profit Forecast - The average revenue forecast for Q4 is approximately 918.25 billion yuan, with a year-on-year growth of 3.8% [3][8] - The median revenue forecast stands at 918.61 billion yuan, also reflecting a year-on-year growth of 3.8% [3][8] - Various financial institutions have provided differing revenue estimates, with Morgan Stanley predicting the highest at 963.14 billion yuan, a year-on-year increase of 8.8% [4][10] Business Performance Analysis - Meituan's third-quarter revenue reached 955 billion yuan, marking a 2.0% year-on-year increase, despite facing operational losses of 198 billion yuan [5][10] - The core local business revenue decreased by 2.8% to 674 billion yuan, while new business revenue grew by 15.9% to 280 billion yuan [5][10] - The company maintains a dominant market position in the high-price segment of the food delivery market, with a market share exceeding 66% [5][10] Strategic Developments - Meituan's flash purchase service continues to lead the market, leveraging a 30-minute delivery guarantee to enhance sales [11][12] - The Keeta service achieved its first monthly profit in the Hong Kong market and is expanding into Saudi Arabia and other Gulf countries, with plans to launch in São Paulo, Brazil [12][10] - The company is actively exploring overseas market opportunities, which are expected to broaden its total addressable market (TAM) and create structural flexibility for future profit growth [12][10]
仕佳光子:公司产品已出口至全球多个国家与地区,获得了包括欧洲、北美、亚太等部分地区客户的认可
Mei Ri Jing Ji Xin Wen· 2025-12-19 11:58
每经AI快讯,有投资者在投资者互动平台提问:请问近两年是否出口欧盟国家? 仕佳光子(688313.SH)12月19日在投资者互动平台表示,公司积极开拓海外市场,产品已出口至全球 多个国家与地区,获得了包括欧洲、北美、亚太等部分地区客户的认可。公司将持续深化全球业务布 局,不断提升公司在全球光通信领域的市场份额和品牌影响力。 (文章来源:每日经济新闻) ...
茂莱光学:销售网络覆盖欧洲、北美、中东等多个国家和地区
Jin Rong Jie· 2025-12-19 11:01
有投资者在互动平台向茂莱光学提问:"请问近两年是否出口欧盟国家?" 作者:公告君 声明:市场有风险,投资需谨慎。本文为AI基于第三方数据生成,仅供参考,不构成个人投资建议。 本文源自:市场资讯 针对上述提问,茂莱光学回应称:"尊敬的投资者,您好!公司建立了完善的运营管理体系和营销服务 体系,销售网络覆盖欧洲、北美、中东等多个国家和地区。感谢您对公司的关注!" ...
东方雨虹(002271.SZ):拟收购巴西Novakem60%股权
Ge Long Hui A P P· 2025-12-19 10:31
公司于2025年12月19日召开第九届董事会第三次会议以9票同意、0票反对、0票弃权的表决结果审议通 过了《关于收购巴西Novakem Indústria QuímicaLtda.60%股权的议案》。 格隆汇12月19日丨东方雨虹(002271.SZ)公布,为积极推进公司国际化战略,持续拓展海外市场,公司 全资子公司东方雨虹巴西有限公司(OYH BRAZIL LTDA.,简称"东方雨虹巴西"或"买方")于北 京 时 间 2025 年 11 月 19 日 ( 巴 西 时 间 2025 年 11 月18 日)与自然人OTTOMASCARENHAS SILVA(简 称"Otto")、HAMBER MARQUES FONSECA(简称"Hamber")、LUIZ SANTOS LEAL(简 称"Luiz")、WALTER MAURICIO FERREIRADE FREITAS(简称"Walter")、HUMBERTO RIBEIRO BENINI(简称"Humberto",与Otto、Hamber、Luiz、Walter合称"交易对方"或"卖方")签署了《SHARE PURCHASE AGREEMENT AND OT ...
运达股份:海外中标容量连续两年翻倍增长并实现新市场突破
南财智讯12月19日电,运达股份在投资者关系活动中表示,2024年公司海外中标容量同比增长超 100%,连续两年实现翻倍增长,在中东、北非等市场首次获取项目订单。公司未来将加速全球战略布 局,加大新业主开拓力度,提升海外订单规模,打造新的盈利增长点。 ...
继峰股份(603997.SH):获得乘用车座椅总成项目定点
Ge Long Hui A P P· 2025-12-19 08:52
格隆汇12月19日丨继峰股份(603997.SH)公布,公司控股子公司格拉默继峰(德国)于近期收到客户的《定 点信》,格拉默继峰(德国)获得了某欧洲豪华品牌主机厂的乘用车座椅总成项目定点,将为客户开发、 生产前中后三排座椅总成产品。 公司再次获得海外高端座椅订单,意味着公司海外豪华汽车品牌客户又增加了一个,标志着公司逐步由 国内乘用车座椅供应商向全球乘用车座椅转型,这将有助于公司进一步拓展海外市场,获得更多海外乘 用车座椅订单,也为公司将来在欧洲地区的生产形成规模经济创造了良好的条件。 根据客户规划,本项目为全球销售车型,预计从2028年9月开始,项目生命周期8.5年,生命周期总金额 预计为98亿元。 在获取 BMW AG(简称"德国宝马")乘用车座椅总成项目定点的基础上,公司在海外又获得一家豪华汽车 品牌客户的项目定点,彰显了海外豪华品牌主机厂对公司在乘用车座椅产品开发设计、技术质量、生产 保障能力的认可。 ...
醋化股份:公司产品已覆盖包括欧盟部分成员国在内的多个国家和地区
Zheng Quan Ri Bao Wang· 2025-12-18 13:04
证券日报网讯 12月18日,醋化股份(603968)在互动平台回答投资者提问时表示,公司多年来持续拓 展海外市场,产品已覆盖包括欧盟部分成员国在内的多个国家和地区。 ...
复星医药子公司签约Clavis Bio 将最多获3.63亿美元付款
12月18日晚间,复星医药(600196)发布公告,公司控股子公司复星医药产业与合作方Clavis Bio签订 《合作及选择权协议》,根据约定,于约定合作期限内,由复星医药产业与Clavis Bio共同选定靶点(基 于Clavis Bio提名)并推进针对获选靶点化合物(即合作项目)的临床前开发。 同时,Clavis Bio会否就合作项目行使选择权,尚存在不确定性;即使Clavis Bio行使选择权,各合作项 目相关开发注册里程碑付款、销售里程碑付款及特许权使用费,仍须以约定的临床、商业化进展、销售 达成情况等作为触发条件。因此,公司基于后期潜在对外许可实际收取的开发注册里程碑付款、销售里 程碑付款及特许权使用费亦存在不确定性。 Clavis Bio将就该等合作项目享有除中国内地、香港、澳门外的全球范围内开发、生产及商业化独家许 可的选择权;无论合作方是否行使上述选择权,复星医药就该等合作项目均享有于中国内地、香港、澳 门独家开发、生产及商业化的权利。 就在通过合作拓展海外市场的同时,复星医药也在通过收购等方式获取新药管线。12月16日,复星医药 发布公告,控股子公司复星医药产业拟出资14.12亿元控股收购绿谷 ...
蜜雪冰城回应美国开首店,外卖平台推独家预售套餐
3 6 Ke· 2025-12-18 01:21
Core Insights - The company "Mixue" is expanding its presence in the U.S., with a new store in Hollywood, Los Angeles, which has attracted attention on social media [1][5] - The store is part of a broader strategy to establish overseas locations, including plans for New York and Mexico [16] Group 1: Store Launch and Consumer Engagement - The Hollywood store is located on the bustling Hollywood Walk of Fame, directly across from the Chinese Theatre [1] - Starting December 15, the company is distributing free drinks featuring the "Snow King" mascot at various locations, including the University of Southern California, to attract students and the Chinese community [3] - The store's design mirrors that of its domestic counterparts, featuring a transparent plastic bottle and a red-themed cap, with the brand name "MIXUE" in English [5] Group 2: Product Offerings and Pricing - The store has launched pre-sale packages on food delivery platforms, with two options priced at $3.99 (approximately 28 RMB), including two drinks and ice cream [5][6] - The drinks available in the pre-sale include options like Taro Grape and Coconut Milk Tea, with a unique sugar level selection ranging from regular to 200% sweetness [6] Group 3: Financial Performance and Expansion - As of mid-2025, Mixue reported a revenue of 14.87 billion RMB, a year-on-year increase of 39.3%, with a net profit of 2.72 billion RMB, up 44.1% [16] - The total number of global stores reached 53,014, with 4,733 located overseas, marking a net increase of 128 international locations [16]
宁德时代与岚图签署十年深化合作协议
Core Viewpoint - CATL and Lantu Motors have signed a 10-year deepening cooperation agreement to enhance collaboration in technology, supply chain, and market expansion in the high-end electric vehicle sector [1] Group 1: Technology Collaboration - CATL will prioritize providing advanced battery technologies to Lantu, including the application of Kirin, Xiaoyao, and Shenging battery brands in Lantu's models [1] - Both companies will work on new ecosystem technologies such as battery swapping, integrated intelligent chassis (CIIC), Panshi chassis, and V2G, while enhancing battery big data collaboration [1] - The goal is to create a comprehensive management loop covering R&D, manufacturing, and operations to improve user experience in terms of range, charging, and safety [1] Group 2: Supply Chain Strategy - The focus will be on promoting localized production capacity and collaborative layout to enhance supply chain agility and security [1] - This strategy aims to effectively respond to external volatility risks and ensure a stable and reliable battery supply for Lantu as it scales up production and competes in the market [1] Group 3: Market Expansion - CATL and Lantu will collaborate on brand innovation and overseas market expansion to enhance their brand influence and competitiveness in the global high-end electric vehicle market [1] - The partnership aims for a comprehensive win-win situation from product development to brand recognition [1]